”­•\˜_•¶i2002”NˆÈ~j

 

 

2017

 

1.        Kaise, A.; Ohta, K.; Shirata, C.; Endo, Y.

Design and Synthesis of p-Carborane-containing Sulfamates as Multitarget Anti-breast Cancer Agents

Bioorg. Med. Chem., 2017, 25, 6417-6426

 

2.        Kaise, A.; Ohta, K.; Endo, Y.

Novel p-carborane-containing multitarget anticancer agents inspired by the metabolism of 17beta-estradiol

Bioorg. Med. Chem., 2017, 25, 6371-6378

 

3.        Ohta, K.; Ogawa, T.; Endo, Y.

Design and synthesis of iodocarborane-containing ligands with high affinity and selectivity toward ERbeta

Bioorg. Med. Chem. Lett., 2017, 27, 4030?4033

 

4.        Taguchi, R.; Hatayama, K.; Takahashi, T.; Hayashi, T.; Sato, Y.; Sato, D.; Ohta, K.; Nakano, H.; Seki, C.; Endo, Y.; Tokuraku, K.; Uwai, K.

Structureactivity relations of rosmarinic acid derivatives for the amyloid beta aggregation inhibition and antioxidant properties

Eur. J. Med. Chem., 2017, 138, 1066-1075

 

2016

 

5.        Watanabe, K.; Hirata, M.; Tominari, T.; Matsumoto, C.: Endo, Y.; Murphy, G.; Nagase, H.; Inada, M.; Miyaura, C.

BA321, a novel carborane analog that binds to androgen and estrogen receptors, acts as a new selective androgen receptor modulator of bone in male mice

Biochem. Biophys. Res. Commun., 2016, 478, 279?285

 

6.        Kaise, A.; Ohta, K.; Endo, Y.

Design, synthesis, and anti-proliferative activity of 1-(4-methoxyphenyl)-12-hydroxymethyl- p-carborane derivatives

Eur. J. Med. Chem., 2016, 122, 257?263

 

7.        Sato, M.; Ohta, K.; Kaise, A.; Aoto, S.; Endo, Y.

Symmetric 4,4'-(piperidin-4-ylidenemethylene)bisphenol derivatives as novel tunable estrogen receptor (ER) modulators

Bioorg. Med. Chem. 2016, 24, 1089-1094

 

8.        Nakagawasai, O.; Nemoto, W.; Onogi,@H.; Moriya, T.; Lin, J-R. Odaira, T.; Yaoita, F.; Ogawa, T.; Ohta, K.; Endo, Y.; Tan-No, K.

BE360, a new selective estrogen receptor modulator, produces antidepressant and antidementia effects through the enhancement of hippocampal cell proliferation in olfactory bulbectomized mice

Behavioural Brain Research, 2016, 297, 315?322

 

2015

 

9.        Certo, M.; Endo, Y.; Ohta, K.; Sakurada, S.; Bagetta, G.; Amantea, D.

Activation of RXR/PPARg underlies neuroprotection by bexarotene in ischemic stroke

Pharmacological Research, 2015, 102, 298-307

 

10.    Kojima, K.; Ogawa, T.; Kitao, S.; Sato, M.; Oda, A.; Ohta, K.; Endo, Y.

Estrogenic activity of bis(4-hydroxyphenyl)methanes with cyclic hydrophobic structure

Bioorg. Med. Chem., 2015, 23, 6900-6911

 

11.    Ohta, K.; Ogawa, T.; Oda, A.; Kaise, A.; Endo, Y.

Design and synthesis of carborane-containing estrogen receptor-beta (ERb)-selective ligands

Bioorg. Med. Chem. Lett, 2015, 25, 4174?4178

 

12.    Ohta, K.; Ogawa, T.; Kaise, A.; Endo, Y.

Synthesis and biological evaluation of novel m-carborane-containing estrogen receptor partial agonists as SERM candidates

Bioorg. Med. Chem. Lett, 2015, 25, 3213?3216

 

13.    Ohta, K.; Chiba, Y.; Kaise, A.; Endo, Y.

Structure?activity relationship study of diphenylamine-based estrogen receptor (ER) antagonists

Bioorg. Med. Chem., 2015, 23, 861?867

 

2014

 

14.    Inomata, K.; Endo, Y.

Synthesis of 2-substituted 1,3-cycloheptanedione via a Lewis acid mediated ring expansion reaction

Heterocycles, 2014, 88, 997-1012

 

15.    Muroi, Y.; Saito, T.; Takahashi, M.; Sakuyama, K.; Niinuma, Y.; Ito, M.; Tsukada, C.; Ohta, K.; Endo, Y.; Oda, A.; Hirasawa, N.; Hiratsuka, M.

Functional characterization of wild-type and 49 CYP2D6 allelic variants for N-desmethyltamoxifen 4-hydroxylation activity

Drug Metab. Pharmacok. 2014, 29, 360-366

 

16.    Ohta, K.; Ogawa, T.; Kaise, A.; Endo, Y.

Novel Estrogen Receptor (ER) Modulators Containing Various Hydrophobic Bent- Core Structures

Bioorg. Med. Chem. 2014, 22, 3508-3514

 

17.    Ohta, K.; Ogawa, T.; Kaise, A.; Oda, A.; Endo, Y.

Aliphatic Substitution of o-Carboranyl Phenols Enhances Estrogen Receptor Beta Selectivity

Chem. Pharm. Bull., 2014, 62, 386-391

 

2013

 

18.    Ohta, K.; Ogawa, T.; Kaise, A.; Endo, Y.

Enhanced Estrogen Receptor beta (ERb) Selectivity of Fluorinated Carborane-containing

ER Modulators

Bioorg. Med. Chem. Lett., 2013, 23, 6555-6558

 

19.    Inomata, K.; Endo, Y.

Synthesis of 2-?Substituted 1,?3-?Cycloheptanedionevia a Lewis Acid Mediated Ring Expansion Reaction

Heterocycles, 2013, 88, 997-1012

 

20.    Ohta, K.; Kawachi, E.; Shudo, K.; Kagechika, H.

Structure-activity Relationship Study on Benzoic Acid Part of Diphenylamine-based Retinoids

Bioorg. Med. Chem. Lett., 2013, 23, 81-84

 

21.    Ohta, K.; Kawachi, E.; Shudo, K.; Kagechika, H.

Structure-activity Relationship Study on Benzoic Acid Part of Diphenylamine-based Retinoids

Bioorg. Med. Chem. Lett., 2013, 23, 81-84

 

 

2012

 

22.    Ohta, K.; Ogawa, T.; Endo, Y.

Estrogenic Activity of B-Fluorinated o-Carborane-1,2-bisphenol Synthesized via SNAr Reaction

Bioorg. Med. Chem., 2012, 20, 4728-4730

 

23.    Fujii, S.; Ohta, K.; Goto, T.; Oda, A.; Masuno, H.; Endo, Y.; Kagechika, H.

Development of Androgen Receptor Ligands by Application of Ten-vertex p-Carborane as a Novel Hydrophobic Core Structure

Med. Chem. Commun., 2012, 3, 680-684

 

24.    Ohta, K.; Taguchi, F.; Endo, Y.

Facile Synthesis and Estrogenic Activity of Arylpyrrole-based Bisphenol Derivatives

Heterocycles, 2012, 86, 165-170

 

2011

 

25.    Fujii, S.; Masuno, H.; Taoda, Y.; Kano, A.; Wongmayura, A.; Nakabayashi, M.; Ito, N.; Shimizu, M.; Kawachi, E.; Hirano, T.; Endo, Y.; Tanatani, A.; Kagechika, H.

Boron Cluster-based Development of Potent Non-Secosteroidal Vitamin D Receptor Ligands: Direct Observation of Hydrophobic Interaction between Protein Surface and Carborane

J. Am. Chem. Soc. 2011, 133, 20933-20941

 

26.    Ohta, K.; Goto, T.; Fujii, S.; Kawahata, M.; Oda, A.; Ohta, S.; Yamaguchi, K.; Hirono, S.; Endo, Y.*

Crystal Structure, Docking Study and Structure?activity Relationship of Carborane-containing Androgen Receptor Antagonist 3-(12-Hydroxymethyl-1,12-dicarba-closo-dodecaboran-1-yl)- benzonitrile.

Bioorg. Med. Chem., 2011, 19, 3540-3548

 

27.    Ohta, K.; Kawachi, E.; Fukasawa, H.; Shudo, K.; Kagechika, H.

Diphenylamine-based Retinoid Anatagonists: Regulation of RAR and RXR Function Depending on the N-substituent

Bioorg. Med. Chem., 2011, 19, 2501-2507

 

28.    Fujii, S.; Yamada, A.; Tomita, K.; Nagano, M.; Goto, T.; Ohta, K.; Harayama, T.; Endo, Y.; Kagechika, H.

p-Carborane Based Androgen Antagonists Active in LNCaP Cells with a Mutated Androgen Receptor

Med. Chem. Commun., 2011, 2, 877-880

 

29.    Wietrzych-Schindler, M.; Szyszka-Niagolov, M.; Ohta, K.; Endo, Y.; Perez, E.; de Lera, A. R.; Chambon, P.; Krezel, W.

Retinoid X Receptor Gamma Is Implicated in Docosahexaenoic Acid Modulation of Despair Behaviors and Working Memory in Mice.

Biol. Psychiatry, 2011, 69, 788-794.

 

30.    Akahane, Y.; Inomata, K.; Endo, Y.

Asymmetric Intramolecular Aldol Reaction Mediated by (S)-N-Substituted -N-(2-pyrrolidinylmethyl)amine to Prepare Wieland-Miescher Ketone.

Heterocycles, 2011, 82: 1727-1737.

 

2010

 

31.    Songkram, C.; Ohta, K.; Yamaguchi, K.; Pichierri, F.; Endo, Y.*

Conformational Control of Benzyl-o-carboranylbenzene Derivatives and Molecular Encapsulation of Acetone into the Dynamically-formed Space of 1,3,5-Tris(2-benzyl-o- carboran-1-yl)benzene.

Inorg. Chem., 2010, 49, 11174?11183.

 

32.    Goto, T.; Ohta, K., Fujii, S.; Ohta, S.;  Endo, Y.*

Design and Synthesis of Androgen Receptor Full Antagonists Bearing a p-Carborane Cage: Promising Ligands for Anti-androgen Withdrawal Syndrome.

J. Med. Chem., 2010, 53, 4917?4926

 

33.    Aizawa, K.; Ohta, K., Endo, Y.*

Synthesis of 3-Aryl-1,2-dicarba-closo-dodecaboranes by Suzuki-Miyaura Coupling Reaction.

Heterocycles, 2010, 80: 369-377.

 

2009

 

34.    Jankowiak, A.; Kaszynski, P.*; Tilford, W. R.; Ohta, K.; Januszko, A.; Nagamine, T.; Endo, Y.

Ring-alkyl Connecting Group Effect on Mesogenic Properties of p-Carborane Derivatives and Their Hydrocarbon Analogues.

Beil, J. Org. Chem., 2009, 5, 1-9.

 

35.    Ohta, K.; Ogawa, T.; Suzuki, T.; Ohta, S.; Endo. Y.*

Novel Estrogen Receptor (ER) Modulators: Carbamate and Thiocarbamate Derivatives with m-Carborane Bisphenol Structure.

Bioorg. Med. Chem., 2009, 17, 7958-7963.

 

36.    Ohta, K.; Yamazaki, H.; Endo, Y.*

Magnesium-Assisted Intramolecular Demethylation Utilizing Carborane C-H Geometry

J. Organomet. Chem., 2009, 694, 1646-1651.

 

37.    Ohta, K.; Konno, S; Endo, Y.*

Complexation of a-Cyclodextrin with Carborane Derivatives in Aqueous Solution

Chem.Pharm. Bull., 2009, 57, 3-7-310.

 

38.    Ogawa, T.; Ohta, K.; Iijima, T.; Suzuki, T.; Ohta, S.; Endo, Y.*

Synthesis and Biological Evaluation of p-Carborane Bisphenols and Their Derivatives: Structure-activity Relationship for Estrogenic Activity

Bioorg. Med. Chem., 2009, 17, 1109-1117.

 

39.    Akahane, Y.; Inomata, K.; Endo, Y.

A new chiral synthesis of Wieland-Miescher ketone catalyzed by a combination of (S)-N-benzyl-(2-pyrrolidinylmethyl)amine derivative and Bronsted acid.

Heterocycles, 2009, 77, 1065-1078.

 

40.    Hirata, M.; Inada, M.; Matsumoto, C.; Takita, M.; Ogawa, T.; Endo, Y.; Miyaura, C.*

A novel carborane Analog, BE360, with a Carbon-containing polyhedral Boron-cluster Is a New Selective Estrogen Receptor Modulator for Bone.

Biochem. Biophys. Res. Commun., 2009, 380, 218-222.

 

2008

 

41.    Kaszynski, P.*; Januszko, A.; Ohta, K.; Nagamine, T.; Potaczek, P.; Young, V. G. Jr.; Endo, Y. Conformational effects on mesophase stability: Numerical comparison of carborane diester homologous series with thier bicyclo[2,2,2]octane, cyclohexane and benzene analogues

Liq. Cryst., 2008, 35, 1169-1190.

 

42.    Fujii, S.; Ohta, K.; Goto, T.; Kagechika, H.; Endo, Y.*

Acidic Heterocycles As Novel Hydrophilic Pharmacophore of Androgen Receptor Ligands with a Carborane Core Structure

Bioorg. Med. Chem., 2009, 17, 344-350.

 

43.    Ohta, K.; Konno, S; Endo, Y.*

Complexation of b-Cyclodextrin with Carborane Derivatives in Aqueous Solution

Tetrahedron Lett. 2008, 49, 6525-6528.

 

44.    Ohta, K.; Chiba, Y.; Ogawa, T.; Endo, Y.*

Promising Core Structure for Nuclear Receptor Ligands: Design and Synthesis of Novel Estrogen Receptor Ligands Based on Diphenylamine Skeleton

Bioorg. Med. Chem. Lett., 2008, 18, 5050-5053.

 

45.    Goto, T.; Fijii, S.; Suzuki, T.; Ohta, S.; Endo, Y.*

Design and Synthesis of Carborane-containing Androgen Receptor (AR) Antagonist Bearing a Pyridine Ring

Bioorg. Med. Chem., 2008, 16, 8022-8028.

 

46.    Nagamine, T.; Inomata, K.*; Endo, Y.

A New Chiral Synthesis of a Bicyclic Endione Containing a Seven-membered Ring Mediated by a Combination of Chiral Amine and Bronsted Acid

Heterocycles, 2008, 76, 1191-1204.

 

47.    Nagamine, T.; Januszko, A.; Ohta, K.; Kaszynski, P.; Endo. Y.

The effect of the linking group on mesogenic properties of three-ring derivatives of p-carborane and biphenyl

Liq. Cryst. 2008, 35, 865?884.

 

48.    Pociecha , D.; Ohta, K.; Januszko, A.; Kaszynski, P.*; Endo, Y.

Symmetric Bent-core Mesogens with m-Carborane and Adamantane As the Central Units

J. Mater. Chem., 2008, 18, 2978 - 2982.

 

49.    Taoda, Y.; Sawabe, T.; Endo, Y.*; Yamaguchi, K.; Fujii, S.; Kagechika, H.*

Identification of an Intermediate in the Deboronation of ortho-Carborane: an Adduct of ortho-Carborane with Two Mucleophiles on One Boron Atom

Chem. Commun., 2008, 2049-2051.

 

50.    Akahane, Y.; Inage, N.; Nagamine, T.; Inomata, K.*; Endo, Y.

An Alternative Chiral Synthesis of Wieland-Miescher Ketone Mediated by (S)-2-(Pyrrolidinylmethyl)pyrrolidine: Remarkable Effects of Bronsted Acid

Heterocycles, 2008, 74, 637-648.

 

2007

 

51.    Ohta, K.; Yamazaki, H.; Pichierri , F.; Kawahata, M.; Yamaguchi, K.; Endo, Y.*

Solid-state Supramolecular Array through Cooperative p-p Interactions of 1-(2-Methoxyphenyl)-o-carborane

Tetrahedron, 2007, 63, 12160-12165.

 

52.    Nagamine, T.; Inomata, K.*; Endo, Y.*

Enantioselective Intramolecular Aldol Reaction Mediated by a Combination of L-Amino Acid and Bronsted Acid to Construct a New Bicyclic Enedione Containing a 7-Membered Ring

Chem.Pharm. Bull., 2007, 55, 1710-1712.

 

53.    Ohta, K.; Yamazaki, H.; Kawahata, M.; Yamaguchi, K.; Pichierri, F.; Endo, Y.*

Proton-Driven Conformational Change in a 2-Aryl-p-carborane Constrained by an Intramolecular C-H---O Hydrogen Bond

Tetrahedron. Lett., 2007, 48, 5231-5234.

 

54.    Ohta, K.; Goto, T.; Yamazaki, H.; Pichierri, F.: Endo, Y.*

Facile and Efficient Synthesis of C-Hydroxycarboranes and C,C'-Dihydroxycarboranes

Inorg. Chem., 2007, 46, 3966-3970

 

55.    Nagamine, T.; Inomata, K.*; Endo, Y.; Paquette, L. A.

Amino Acid-mediated Intramolecular Asymmetric Aldol Reaction to Construct a New Chiral Bicyclic Enedione Containing a 7-Membered Ring: Remarkable Inversion of Enantioselectivity Compared to the 6-Membered Ring.

J. Org. Chem., 2007, 72, 123-131.

 

2006

 

56.    Nagamine, T.; Januszko, A.; Kaszynski, P.*; Ohta, K.; Endo, Y.

Masogenic, Optical and Dielectric Properties of 5-Substituted 2-[12?(4-pentyloxyphenyl)-p- carboran-1-yl][1,3]dioxanes

J. Mater. Chem., 2006, 6, 3836-3843.

 

57.    Calleja, C.; Messaddeq, N.; Chapellier, B.; Yang, H.; Krezel, W.; Li, M.; Metzger, D.; Marcrez, B.; Ohta, K.; kagechika, H,; Endo, Y.; Mark, M.; Ghyselinck, N. B.; Chambon, P.*

Genetic and Pharmacological Evidence that a Retinoic Acid Cannot be the RXR-activating Ligand in Mouse Epidermis Keratinocytes.

Genes Dev., 2006, 20, 1525 - 1538.

 

58.    Ogawa, T.; Ohta, K.; Yoshimi, T.; Yamazaki, H.; Suzuki, T.; Ohta, S.; Endo, Y.*

m-Carborane Bisphenol Structure as a Pharmacophore for Selective Estrogen Receptor Modulators

Bioorg. Med. Chem. Lett., 2006, 16, 3943-3946.

 

59.    Ohta, K.; Yamazaki, H.; Endo, Y.*

NMR Study of 1,2-Dicarba-closo-dodecaboranes: Intramolecular C-H---O Hydrogen Bonding in Solution.

Tetrahedron. Lett., 2006, 47, 1937-1940.

 

2005

 

60.    Ohta, K.; Goto, T.; Endo, Y.*

1,2-Dicarba-closo-dodecaboran-1-yl Naphthalene Derivatives.

Inorg. Chem., 2005, 23, 8569-8573.

 

61.    Nagamine, T.; Januszko, A.; Ohta, K.; Kaszynski, P.; Endo, Y.

A comparison of Mesogenic Properties of p-Carborane-1,12-dicarbaldehyde Schiff Bases with Their Terephthaldehyde Analogues.

Liq. Cryst. 2005, 32, 985-995.

 

62.    Goto, T.; Ohta, K.; Suzuki, T.; Ohta, S.; Endo, Y.*

Design and Synthesis of Novel Androgen Receptor (AR) Antagonists with Sterically Bulky Icosahedral Carboranes.

Bioorg. Med. Chem., 2005, 13, 6414-6424.

 

63.    Fujii, S.; Goto, T.; Ohta, K.; Hashimoto, Y.; Suzuki, T.; Ohta, S.; Endo, Y.*

Potent Androgen Antagonists Based on Carborane As a Hydrophobic Core Structure.

J. Med. Chem. 2005, 48, 4654-4662.

 

64.    Endo, Y*.; Yoshimi, T.; Ohta, K.; Suzuki, T.; Ohta, S.

Potent Estrogen Receptor Ligands Based on Bisphenols with Globular Hydrophobic Cores.

J. Med. Chem. 2005, 48, 3941-3944.

 

65.    Endo, Y.*; Songkram, C.; Ohta, K.; Yamaguchi, K.

Synthesis of Distorted Molecules Based on Spatial Control with Icosahedral Carboranes

J. Organomet. Chem., 2005, 690, 2750-2756.

 

66.    Yamazaki, H.; Ohta, K.; Endo, Y.*

Regioselective Synthesis of Triiodo-o-carboranes and Tetraiodo-o-carborane.

Tetrahedron Lett., 2005, 46, 3119-3122.

 

67.    Endo, Y.*; Songkram, C.; Ohta, K.; Kaszynski, P.; Yamaguchi, K.

A Distorted Benzene Bearing Two Bulky Substituents on Adjacent Positions: Structure of 1,2-Bis(1,2-Dicarba-closo-dodecaboran-1-yl)benzene.

Tetrahedron Lett., 2005, 46, 699-702.

 

68.    Ohta, K.; Goto, T.; Endo, Y.*

New Synthetic Method of 1,2-Diaryl-1,2-dicarba-closo-dodecaboranes Employing Aromatic Nucleophilic Substitution (SNAr) Reaction.

Tetrahedron Lett., 2005, 46, 483-485.

 

69.    Fujii, S.; Hashimoto, Y.; Suzuki, T.; Ohta, S.; Endo, Y*

A new Class of Androgen Receptor Antagonists Bearing Carborane in Place of a Steroidal Skeleton.

BioMed. Chem. Lett. 2005, 15, 227-230.

             

2004

 

70.    Ohta, K.; Iijima, T.; Kawachi, E.; Kagechika, H.; Endo, Y*

Novel Retinoid X Receptor (RXR) Antagonists Having a Dicarba-closo-dodecaborane as a Hydrophobic Moiety.

BioMed. Chem. Lett. 2004, 14, 5913-5918.

 

71.    Endo, Y.*; Ohta, K.; Yoshimi, T.; Yamaguchi, K. A New Application of Inorganic Cluster, Carboranes for Medicinal Drug Design and Molecular Construction.

Phosphorous, Sulfur, and Silicon. 2004, 179, 799-802.

 

72.    Ohta, K.; Januszko, A.; Kaszynski, P.; Nagamine, T.; Sasnouski, G.; Endo, Y.

Structural Effects in Three-Ring Mesogenic Derivatives of p-Carborane and Their Hydrocarbon Analogs.

Liq. Cryst. 2004, 31, 1-12.

 

73.    Suzuki, K.; Inomata, K.; Endo, Y.

Enantiocontrllooed Synthesis of Jasmonates via Tandem Retro-Diels-Alder-Ene reaction Activated by a Silyl Substituent

Org. Lett., 2004, 6, 409-411.

 

2003

 

74.    Taoda, Y.; Endo, Y.*

Electronic Effects of Icosahedral Carboranes: Mechanistic Alteration in Solvolysis of a-(o-Carboranyl)benzyl Tosylates by Electronic Effect of Substituents

Tetrahedron Lett., 2003, 44, 8177-8181.

 

75.    Endo, Y.*; Yamamoto, K.; Kagechika, H.

Utility of Boron Clusters for Drug Design. Relation between Estrogen Receptor Binding Affinity and Hydrophobicity of Phenols Bearing Various Types of Carboranyl Groups.

BioMed. Chem. Lett. 2003, 13, 4089-4092.

 

76.    Johnsamuel, J.; Byun, Y.; Jones, T. P.; Endo, Y.; Tjarks, W.

A Convenient Method for the Computer-Aided Molecular Design of Carborane Containing Compounds.

BioMed. Chem. Lett. 2003, 13,3213-3216.

 

77.    Endo, Y.*; Yoshimi, T.; Miyaura, C.

Boron Clusters for Medicinal Drug Design: Selective Estrogen Receptor Modulators Bearing Carborane

Pure Appl. Chem., 2003, 75, 1197-1205.

 

78.    Johnsamuel, J.; Byun, Y.; Jones, T. P.; Endo, Y.; Tjarks, W.

A New Strategy for Molecular Modeling and Receptor-based Design of Carborane Containing Compounds.

J. Organomet. Chem., 2003, 680, 223-231.

 

79.    Suzuki, K.; Inomata, K.; Endo, Y.

New Chiral Synthesis Methyl and Allyl Disubstituted Butyro Lactone: A Formal Synthesis of (-)-Ngaione

Heterocycles, 2003, 60, 2743-2748.

 

2002

 

80.    Igarashi, Y.; Sekine, A.; Uehara, Y.; Yamaguchi, K.; Endo, Y.; Furumai, T.; Oki, T.

Anicequol, a Novel Inhibitor for Anchorage-independent Growth of Tumor Cells from Penicillium sp. TP-F0213

J. Antibiotics., 2002, 55, 371-376.

 

81.    Toya, T.; Fukasawa, H.; Masui, A.; Endo, Y.*

Potent and Selective Partial Ecdysone Agonist Activity of Chromafenozide in Sf9 Cells

Biochem. Biophys. Res. Commun., 2002, 292, 1087-1091.

 

82.    Endo,Y.*; Songkram, C.; Yamasaki, R.; Tanatani, A.;Kagechika, H.;Takaishi, K.;Yamaguchi, K.

Molecular Construction Based on Icosahedral Carboranes and Aromatic N,Nf-Dimethylurea Groups. Aromatic Layered Molecules and a Transition Metal Complex

J. Organomet. Chem., 2002, 657, 48-58.

 

83.    Toya, T.; Yamaguchi, K.; Endo, Y.*

Cyclic Dibenzoylhydrazines Reproducing the Conformation of Ecdyson Agonists, RH-5849. Importance of Hydrogen-bonding Character of NH Group

BioMed. Chem., 2002, 10, 953-961.

 

 

 

 


”­•\˜_•¶ (1977-2001)

 

 

 

ƒgƒbƒvƒy[ƒW‚É–ß‚é